Sunstone Life Science Ventures is an independent European VC investment firm that supports innovative companies operating in the life science therapeutics sector. It offers business, operational, and financial assistance through collaborating with international Life Sciences executives. Sunstone supported over 45 companies, including F2G, a biopharmaceutical company that develops drugs to treat life-threatening fungal diseases, OxThera, which develops novel therapy for primary hyperoxaluria, Cantagria, a company developing antibody-based treatments for life-threatening diseases.